Patients in the study will have been on lipid lowering drugs at a stable dose for the last three months before the designated study visit. [clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33]

Patients in the study will have been on lipid lowering drugs at a stable dose for the last three months before the designated study visit. [clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33

Patients in the study will have been on lipid lowering drugs at a stable dose for the last three months before the designated study visit. [clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33
Bio2RDF identifier
b32f2ab1e85e2a98f9cb0db0aa29fd33
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33
identifier
clinicaltrials_resource:b32f2ab1e85e2a98f9cb0db0aa29fd33
title
Patients in the study will hav ...... re the designated study visit.
@en
inDataset
type
label
Patients in the study will hav ...... f2ab1e85e2a98f9cb0db0aa29fd33]
@en